Surgical ablation of atrial fibrillation (AF) has received multisociety guideline-directed Class I recommendations on the basis of safety and longitudinal outcome. [1][2][3] The effectiveness of catheter-based ablation for persistent atrial fibrillation remains limited, often requiring multiple separate attempts for efficacy. [3][4][5] Furthermore, recent epicardial minimally invasive surgical ablation techniques, particularly subxiphoid, are arrhythmically and antomically incomplete and have potential major safety concerns. [6][7][8] Despite the known effectiveness of the cut-and-sew Coxmaze III, there exists a reluctance on the part of patients, referring cardiologists, and surgeons to carry out a sternotomy for a stand-alone cut-and-sew surgical Cox-maze. Fortunately, the electrophysiologic principles of the Coxmaze III biatrial lesions can be identically and transmurally replicated with alternate power sources consisting of bipolar radiofrequency and/or cryothermia, as the Cox-maze IV procedure (Figure 1). 9,10 Only surgical cryothermia has the ability to consistently construct all complete biatrial lesions as a sole power source. 10 Minimally invasive platforms for the full biatrial Coxmaze using peripheral cardiopulmonary bypass (CPB) and a right mini-thoracotomy have been applied increasingly over the past several years. 11,12 Since 2016, we have exclusively used the robotic platform to perform the complete biatrial Cox-maze lesions using cryothermic energy to apply the identical lesion set in more than 150 patients, and here we outline our technique. In conjunction with robotic performance of surgical ablation, this versatile platform readily permits concomitant mitral repair or replacement, tricuspid valve repair or replacement, removal of intracardiac tumors, atrial septal defects, and, more recently, aortic valve replacement.